#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Necrotising myositis Waldenstrom's macroglobulinaemia recurrent Cutaneous lupus erythematosus Ewing's sarcoma metastatic Hairy cell leukaemia recurrent B precursor type acute leukaemia Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Hereditary optic atrophy Retinopathy proliferative Liposarcoma recurrent Small cell lung cancer Sarcoma Osteochondrodysplasia Complex regional pain syndrome Chordoma More trials…

    Learn about Rare Diseases

    Sarcoidosis – Trials in Disease Netherton’s syndrome – Treatment Progressive supranuclear palsy – Diagnostics Advanced systemic mastocytosis – Trials in Disease Hereditary angioedema – Basic Information Myelodysplastic syndrome – Treatment Hairy cell leukaemia Basal cell naevus syndrome – Treatment Mastocytosis – Basic Information SAPHO syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dydrogesterone Isotretinoin Artemisia Vulgaris Valganciclovir Hydrochloride Lixisenatide Glycerol Phenylbutyrate Morf-057 Umeclidinium Bromide Pivekimab Sunirine Rusfertide Idecabtagene Vicleucel Sodium Iotalamate (125I) Ribonucleic Acid Warfarin GT-002 Follitropin Beta Povetacicept Tipiracil Ixekizumab Brexucabtagene Autoleucel More therapies…

    Learn about Your Condition

    Psychotic disorder Procedural anxiety Laryngeal cancer stage II Mitral valve disease Complex regional pain syndrome Neuroendocrine carcinoma Influenza Nicotine dependence Uveal melanoma Polycystic liver disease Tumour thrombosis Spinal muscular atrophy Morning sickness Chronic hepatitis C Muscle hypertrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Testing UCPVax vaccine with or without pembrolizumab and temozolomide in patients with unmethylated MGMT glioblastoma after initial treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Ucp4
    • Temozolomide
    • Pembrolizumab
    France

  • A study on ketamine maintenance treatment for patients with treatment-resistant major depression disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Depression
    • Major depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    Norway

  • Study of pirtobrutinib combined with immuno-chemotherapy for previously untreated patients with symptomatic chronic lymphocytic leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Pirtobrutinib
    France

  • A Study of Mibavademab for Weight Loss in Children, Adolescents and Adults with Obesity Caused by LEP Gene Mutations

    Not yet recruiting

    3 1 1
    Germany

  • A Study of Encoberminogene Rezmadenovec Gene Therapy for Patients with Refractory Angina Due to Coronary Artery Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Angina pectoris
    Investigated Drugs:
    • 13N-AMMONIA
    Belgium Germany Hungary The Netherlands Poland

  • Testing Antibiotic Treatment Strategies for Patients with Bladder Bacteria Without Symptoms Receiving Botulinum Toxin A Bladder Injections

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefixime
    • Ofloxacin
    • Nitrofurantoin
    France
Previous Page
1 … 759 760 761 762 763 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!